カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のヒト狂犬病免疫グロブリン（HRIG）市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Human Rabies Immune Globulin (HRIG) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19397）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19397
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：100
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のヒト狂犬病免疫グロブリン（HRIG）市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ヒト狂犬病免疫グロブリン（HRIG）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のヒト狂犬病免疫グロブリン（HRIG）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヒト狂犬病免疫グロブリン（HRIG）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・200IU、500IU

用途別セグメントは次のように区分されます。
・カテゴリーⅡばく露、カテゴリーⅢばく露

世界のヒト狂犬病免疫グロブリン（HRIG）市場の主要な市場プレーヤーは以下のとおりです。
・CSL Behring、Grifols、Sanofi、Sichuan Yuanda Shuyang、CNBG、Kamada、CBPO、Shuanglin Bio、Weiguang Bio、Shanghai RAAS、Bharat Serum、VINS

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒト狂犬病免疫グロブリン（HRIG）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒト狂犬病免疫グロブリン（HRIG）メーカーの企業概要、2019年～2022年までのヒト狂犬病免疫グロブリン（HRIG）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒト狂犬病免疫グロブリン（HRIG）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ヒト狂犬病免疫グロブリン（HRIG）の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのヒト狂犬病免疫グロブリン（HRIG）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒト狂犬病免疫グロブリン（HRIG）市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヒト狂犬病免疫グロブリン（HRIG）の産業チェーンを掲載しています。
・第13、14、15章では、ヒト狂犬病免疫グロブリン（HRIG）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ヒト狂犬病免疫グロブリン（HRIG）の概要
- 種類別分析（2017年vs2021年vs2028年）：200IU、500IU
- 用途別分析（2017年vs2021年vs2028年）：カテゴリーⅡばく露、カテゴリーⅢばく露
- 世界のヒト狂犬病免疫グロブリン（HRIG）市場規模・予測
- 世界のヒト狂犬病免疫グロブリン（HRIG）生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- CSL Behring、Grifols、Sanofi、Sichuan Yuanda Shuyang、CNBG、Kamada、CBPO、Shuanglin Bio、Weiguang Bio、Shanghai RAAS、Bharat Serum、VINS
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：200IU、500IU
・用途別分析2017年-2028年：カテゴリーⅡばく露、カテゴリーⅢばく露
・ヒト狂犬病免疫グロブリン（HRIG）の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒト狂犬病免疫グロブリン（HRIG）のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒト狂犬病免疫グロブリン（HRIG）のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒト狂犬病免疫グロブリン（HRIG）の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒト狂犬病免疫グロブリン（HRIG）の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Human Rabies Immune Globulin (HRIG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Rabies Immune Globulin (HRIG) market size is estimated to be worth US$ 407.5 million in 2021 and is forecast to a readjusted size of USD 605.4 million by 2028 with a CAGR of 5.8% during review period. Category II Exposure accounting for % of the Human Rabies Immune Globulin (HRIG) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 200IU segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Rabies Immune Globulin (HRIG) include CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, and CNBG, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Rabies Immune Globulin (HRIG) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
200IU
500IU
Market segment by Application can be divided into
Category II Exposure
Category III Exposure
The key market players for global Human Rabies Immune Globulin (HRIG) market are listed below:
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rabies Immune Globulin (HRIG) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Rabies Immune Globulin (HRIG), with price, sales, revenue and global market share of Human Rabies Immune Globulin (HRIG) from 2019 to 2022.
Chapter 3, the Human Rabies Immune Globulin (HRIG) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rabies Immune Globulin (HRIG) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Rabies Immune Globulin (HRIG) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Rabies Immune Globulin (HRIG).
Chapter 13, 14, and 15, to describe Human Rabies Immune Globulin (HRIG) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Human Rabies Immune Globulin (HRIG) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Rabies Immune Globulin (HRIG) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 200IU
1.2.3 500IU
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Rabies Immune Globulin (HRIG) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Human Rabies Immune Globulin (HRIG) Market Size & Forecast
1.4.1 Global Human Rabies Immune Globulin (HRIG) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Rabies Immune Globulin (HRIG) Sales in Volume (2017-2028)
1.4.3 Global Human Rabies Immune Globulin (HRIG) Price (2017-2028)
1.5 Global Human Rabies Immune Globulin (HRIG) Production Capacity Analysis
1.5.1 Global Human Rabies Immune Globulin (HRIG) Total Production Capacity (2017-2028)
1.5.2 Global Human Rabies Immune Globulin (HRIG) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Rabies Immune Globulin (HRIG) Market Drivers
1.6.2 Human Rabies Immune Globulin (HRIG) Market Restraints
1.6.3 Human Rabies Immune Globulin (HRIG) Trends Analysis
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Human Rabies Immune Globulin (HRIG) Product and Services
2.1.4 CSL Behring Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Human Rabies Immune Globulin (HRIG) Product and Services
2.2.4 Grifols Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Human Rabies Immune Globulin (HRIG) Product and Services
2.3.4 Sanofi Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sichuan Yuanda Shuyang
2.4.1 Sichuan Yuanda Shuyang Details
2.4.2 Sichuan Yuanda Shuyang Major Business
2.4.3 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Product and Services
2.4.4 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CNBG
2.5.1 CNBG Details
2.5.2 CNBG Major Business
2.5.3 CNBG Human Rabies Immune Globulin (HRIG) Product and Services
2.5.4 CNBG Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kamada
2.6.1 Kamada Details
2.6.2 Kamada Major Business
2.6.3 Kamada Human Rabies Immune Globulin (HRIG) Product and Services
2.6.4 Kamada Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 CBPO
2.7.1 CBPO Details
2.7.2 CBPO Major Business
2.7.3 CBPO Human Rabies Immune Globulin (HRIG) Product and Services
2.7.4 CBPO Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Shuanglin Bio
2.8.1 Shuanglin Bio Details
2.8.2 Shuanglin Bio Major Business
2.8.3 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Product and Services
2.8.4 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Weiguang Bio
2.9.1 Weiguang Bio Details
2.9.2 Weiguang Bio Major Business
2.9.3 Weiguang Bio Human Rabies Immune Globulin (HRIG) Product and Services
2.9.4 Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Shanghai RAAS
2.10.1 Shanghai RAAS Details
2.10.2 Shanghai RAAS Major Business
2.10.3 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Product and Services
2.10.4 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bharat Serum
2.11.1 Bharat Serum Details
2.11.2 Bharat Serum Major Business
2.11.3 Bharat Serum Human Rabies Immune Globulin (HRIG) Product and Services
2.11.4 Bharat Serum Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 VINS
2.12.1 VINS Details
2.12.2 VINS Major Business
2.12.3 VINS Human Rabies Immune Globulin (HRIG) Product and Services
2.12.4 VINS Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Rabies Immune Globulin (HRIG) Breakdown Data by Manufacturer
3.1 Global Human Rabies Immune Globulin (HRIG) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Rabies Immune Globulin (HRIG)
3.4 Market Concentration Rate
3.4.1 Top 3 Human Rabies Immune Globulin (HRIG) Manufacturer Market Share in 2021
3.4.2 Top 6 Human Rabies Immune Globulin (HRIG) Manufacturer Market Share in 2021
3.5 Global Human Rabies Immune Globulin (HRIG) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Rabies Immune Globulin (HRIG) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Rabies Immune Globulin (HRIG) Market Size by Region
4.1.1 Global Human Rabies Immune Globulin (HRIG) Sales in Volume by Region (2017-2028)
4.1.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2028)
4.2 North America Human Rabies Immune Globulin (HRIG) Revenue (2017-2028)
4.3 Europe Human Rabies Immune Globulin (HRIG) Revenue (2017-2028)
4.4 Asia-Pacific Human Rabies Immune Globulin (HRIG) Revenue (2017-2028)
4.5 South America Human Rabies Immune Globulin (HRIG) Revenue (2017-2028)
4.6 Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Rabies Immune Globulin (HRIG) Sales in Volume by Type (2017-2028)
5.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2028)
5.3 Global Human Rabies Immune Globulin (HRIG) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Rabies Immune Globulin (HRIG) Sales in Volume by Application (2017-2028)
6.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2028)
6.3 Global Human Rabies Immune Globulin (HRIG) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028)
7.2 North America Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028)
7.3 North America Human Rabies Immune Globulin (HRIG) Market Size by Country
7.3.1 North America Human Rabies Immune Globulin (HRIG) Sales in Volume by Country (2017-2028)
7.3.2 North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028)
8.2 Europe Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028)
8.3 Europe Human Rabies Immune Globulin (HRIG) Market Size by Country
8.3.1 Europe Human Rabies Immune Globulin (HRIG) Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028)
9.2 Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028)
9.3 Asia-Pacific Human Rabies Immune Globulin (HRIG) Market Size by Region
9.3.1 Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028)
10.2 South America Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028)
10.3 South America Human Rabies Immune Globulin (HRIG) Market Size by Country
10.3.1 South America Human Rabies Immune Globulin (HRIG) Sales in Volume by Country (2017-2028)
10.3.2 South America Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028)
11.2 Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028)
11.3 Middle East & Africa Human Rabies Immune Globulin (HRIG) Market Size by Country
11.3.1 Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Rabies Immune Globulin (HRIG) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Rabies Immune Globulin (HRIG)
12.3 Human Rabies Immune Globulin (HRIG) Production Process
12.4 Human Rabies Immune Globulin (HRIG) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Rabies Immune Globulin (HRIG) Typical Distributors
13.3 Human Rabies Immune Globulin (HRIG) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Human Rabies Immune Globulin (HRIG) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Rabies Immune Globulin (HRIG) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 4. CSL Behring Major Business
Table 5. CSL Behring Human Rabies Immune Globulin (HRIG) Product and Services
Table 6. CSL Behring Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Grifols Basic Information, Manufacturing Base and Competitors
Table 8. Grifols Major Business
Table 9. Grifols Human Rabies Immune Globulin (HRIG) Product and Services
Table 10. Grifols Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Human Rabies Immune Globulin (HRIG) Product and Services
Table 14. Sanofi Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 16. Sichuan Yuanda Shuyang Major Business
Table 17. Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Product and Services
Table 18. Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. CNBG Basic Information, Manufacturing Base and Competitors
Table 20. CNBG Major Business
Table 21. CNBG Human Rabies Immune Globulin (HRIG) Product and Services
Table 22. CNBG Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Kamada Basic Information, Manufacturing Base and Competitors
Table 24. Kamada Major Business
Table 25. Kamada Human Rabies Immune Globulin (HRIG) Product and Services
Table 26. Kamada Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. CBPO Basic Information, Manufacturing Base and Competitors
Table 28. CBPO Major Business
Table 29. CBPO Human Rabies Immune Globulin (HRIG) Product and Services
Table 30. CBPO Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 32. Shuanglin Bio Major Business
Table 33. Shuanglin Bio Human Rabies Immune Globulin (HRIG) Product and Services
Table 34. Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 36. Weiguang Bio Major Business
Table 37. Weiguang Bio Human Rabies Immune Globulin (HRIG) Product and Services
Table 38. Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 40. Shanghai RAAS Major Business
Table 41. Shanghai RAAS Human Rabies Immune Globulin (HRIG) Product and Services
Table 42. Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Bharat Serum Basic Information, Manufacturing Base and Competitors
Table 44. Bharat Serum Major Business
Table 45. Bharat Serum Human Rabies Immune Globulin (HRIG) Product and Services
Table 46. Bharat Serum Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. VINS Basic Information, Manufacturing Base and Competitors
Table 48. VINS Major Business
Table 49. VINS Human Rabies Immune Globulin (HRIG) Product and Services
Table 50. VINS Human Rabies Immune Globulin (HRIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Human Rabies Immune Globulin (HRIG) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Human Rabies Immune Globulin (HRIG) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Human Rabies Immune Globulin (HRIG), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Human Rabies Immune Globulin (HRIG) Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Human Rabies Immune Globulin (HRIG) Production Site of Key Manufacturer
Table 56. Human Rabies Immune Globulin (HRIG) New Entrant and Capacity Expansion Plans
Table 57. Human Rabies Immune Globulin (HRIG) Mergers & Acquisitions in the Past Five Years
Table 58. Global Human Rabies Immune Globulin (HRIG) Sales by Region (2017-2022) & (K Units)
Table 59. Global Human Rabies Immune Globulin (HRIG) Sales by Region (2023-2028) & (K Units)
Table 60. Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units)
Table 63. Global Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units)
Table 64. Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Human Rabies Immune Globulin (HRIG) Price by Type (2017-2022) & (US$/Unit)
Table 67. Global Human Rabies Immune Globulin (HRIG) Price by Type (2023-2028) & (US$/Unit)
Table 68. Global Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units)
Table 69. Global Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units)
Table 70. Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Human Rabies Immune Globulin (HRIG) Price by Application (2017-2022) & (US$/Unit)
Table 73. Global Human Rabies Immune Globulin (HRIG) Price by Application (2023-2028) & (US$/Unit)
Table 74. North America Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022) & (K Units)
Table 75. North America Human Rabies Immune Globulin (HRIG) Sales by Country (2023-2028) & (K Units)
Table 76. North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units)
Table 79. North America Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units)
Table 80. North America Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units)
Table 81. North America Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units)
Table 82. Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022) & (K Units)
Table 83. Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2023-2028) & (K Units)
Table 84. Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units)
Table 87. Europe Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units)
Table 88. Europe Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units)
Table 89. Europe Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units)
Table 98. South America Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022) & (K Units)
Table 99. South America Human Rabies Immune Globulin (HRIG) Sales by Country (2023-2028) & (K Units)
Table 100. South America Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Human Rabies Immune Globulin (HRIG) Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units)
Table 103. South America Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units)
Table 104. South America Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units)
Table 105. South America Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units)
Table 114. Human Rabies Immune Globulin (HRIG) Raw Material
Table 115. Key Manufacturers of Human Rabies Immune Globulin (HRIG) Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Human Rabies Immune Globulin (HRIG) Typical Distributors
Table 119. Human Rabies Immune Globulin (HRIG) Typical Customers
List of Figures
Figure 1. Human Rabies Immune Globulin (HRIG) Picture
Figure 2. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type in 2021
Figure 3. 200IU
Figure 4. 500IU
Figure 5. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application in 2021
Figure 6. Category II Exposure
Figure 7. Category III Exposure
Figure 8. Global Human Rabies Immune Globulin (HRIG) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Human Rabies Immune Globulin (HRIG) Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Human Rabies Immune Globulin (HRIG) Sales (2017-2028) & (K Units)
Figure 11. Global Human Rabies Immune Globulin (HRIG) Price (2017-2028) & (US$/Unit)
Figure 12. Global Human Rabies Immune Globulin (HRIG) Production Capacity (2017-2028) & (K Units)
Figure 13. Global Human Rabies Immune Globulin (HRIG) Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Human Rabies Immune Globulin (HRIG) Market Drivers
Figure 15. Human Rabies Immune Globulin (HRIG) Market Restraints
Figure 16. Human Rabies Immune Globulin (HRIG) Market Trends
Figure 17. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Manufacturer in 2021
Figure 18. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Manufacturer in 2021
Figure 19. Human Rabies Immune Globulin (HRIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Human Rabies Immune Globulin (HRIG) Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Human Rabies Immune Globulin (HRIG) Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2017-2028)
Figure 23. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2017-2028)
Figure 24. North America Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (USD Million)
Figure 25. Europe Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (USD Million)
Figure 27. South America Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (USD Million)
Figure 29. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028)
Figure 30. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2017-2028)
Figure 31. Global Human Rabies Immune Globulin (HRIG) Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028)
Figure 33. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2017-2028)
Figure 34. Global Human Rabies Immune Globulin (HRIG) Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028)
Figure 36. North America Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028)
Figure 37. North America Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2017-2028)
Figure 38. North America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2017-2028)
Figure 39. United States Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028)
Figure 43. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028)
Figure 44. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2017-2028)
Figure 45. Europe Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2017-2028)
Figure 46. Germany Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2017-2028)
Figure 55. China Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028)
Figure 62. South America Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028)
Figure 63. South America Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2017-2028)
Figure 64. South America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Human Rabies Immune Globulin (HRIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Human Rabies Immune Globulin (HRIG) in 2021
Figure 76. Manufacturing Process Analysis of Human Rabies Immune Globulin (HRIG)
Figure 77. Human Rabies Immune Globulin (HRIG) Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の狂犬病免疫グロブリン市場2022年：市場規模予測（～2028年）
  • ヒト破傷風用免疫グロブリンのグローバル市場展望 2023年-2029年：注射剤、フリーズドライ注射剤
  • 世界のヒト破傷風免疫グロブリン市場2022年：市場規模予測（～2028年）
  • 世界のウマ狂犬病免疫グロブリン（ERIG）市場2022年：市場規模予測（～2028年）
  • 免疫グロブリン皮下注射のグローバル市場展望 2023年-2029年：2g、4g、10g、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19397 )"世界のヒト狂犬病免疫グロブリン（HRIG）市場2022年：市場規模予測（～2028年）" (英文：Global Human Rabies Immune Globulin (HRIG) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。